Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve.

Front Cell Neurosci · 2018 · PMC6169322 · PMID 30319357

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a decreasing trendp = 0.06so close (0.05 < p ≤ 0.1)

A decreasing trend of PARP-1 level was observed in the S100B I group (0.8 ± 0.3 units) compared to the PBS group (1.8 ± 0.2 units, p = 0.06; Figure 2E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.